The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic rhinosinusitis ...
The FDA approved Amgen's and AstraZeneca's drug to treat chronic rhinosinusitis with nasal polyps, an inflammatory condition of the sinuses and nasal passages. The companies said the approval was ...
Our noses are home to a variety of bacteria. Some, like Staphylococcus aureus or Streptococcus pneumoniae, can cause serious ...
Tribune Content Agency on MSN
The Medicine Cabinet: Ask the Harvard Experts: Are sinus infections contagious?
Sinus infections, also known as sinusitis, can leave us feeling miserable with symptoms like nasal congestion, facial pain ...
Runny noses and snot are not typically associated with dogs. But, dogs can get runny noses but for very different reasons.
The EVEREST trial directly compared biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting ...
The trial included 360 adults with bilateral nasal polyps (NPS ≥5) with symptoms of nasal congestion ... upper respiratory tract infection, and cough. A key limitation was the relatively short ...
Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people worldwide, or about 12% of the population. Defined as a long-lasting ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Between Sept 27, 2021, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback